Pfizer Gets PTAB To Wipe Out Rest Of Sanofi's Lantus Patent
The Patent Trial and Appeal Board has nixed the two claims left standing in a Sanofi-Aventis patent covering the Lantus SoloStar disposable insulin injection pen after finding back in April in...To view the full article, register now.
Already a subscriber? Click here to view full article